| Net Cash Provided by (Used in) Operating Activities |
$7,106,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$137,432,000 |
USD |
-369% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
700,000,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
75,917,730 |
shares |
-83% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$130,326,000 |
USD |
56% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$235,856,000 |
USD |
-34% |
Q2 2025 |
Q2 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$8,702,000 |
USD |
1.4% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$150,870,000 |
USD |
7.8% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Additional Paid in Capital |
$3,129,954,000 |
USD |
-1.8% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Interest Expense |
$20,184,000 |
USD |
-63% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |